Lipid management in patients with chronic kidney disease
Charles J. Ferro(Queen Elizabeth Hospital Birmingham), Carmine Zoccali(Università Campus Bio-Medico), Gunnar H. Heine(Saarland University), Patrick Rossignol(Inserm), Mehmet Kanbay(Koç University), Francesca Mallamaci(Metabolism and Renal Physiology), Pantelis Sarafidis(Ippokrateio General Hospital of Thessaloniki), Gérard M. London(Hôpital Européen Georges-Pompidou), Patrick B. Mark(University of Glasgow), Alberto Ortíz(Fundación Renal), Marianne C. Verhaar(Utrecht University), Raymond Vanholder(Baylor College of Medicine), Jolanta Małyszko, José Manuel Valdivielso(Instituto de Salud Carlos III), Ziad Massy(Université de Versailles Saint-Quentin-en-Yvelines), Robert Ekart(University of Maribor)
Cited by 275
Related Papers
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
|European Heart Journal|2024|1.9k
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
|The Lancet|2001|1.1k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k